Intersect ENT
Acquired
- Headquarters
- Menlo Park, California
- Employees
- 201–500
- Founded
- 2003
- Business Model
- B2B
- Website
- intersectent.com
- Total Funding
- $60.0M
- Last Round
- $30.0M Series DFeb 2013
- Type
- Public
About
Intersect ENT was a Menlo Park, California-based medical device company that developed and commercialized drug-eluting sinus implants, including the PROPEL and SINUVA products, designed to improve outcomes for ENT surgical patients. Founded in 2003, it was publicly traded before being acquired by Medtronic in May 2022 for approximately $1.1 billion.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account